Examen

TEST BANK FOR FOCUS ON NURSING PHARMACOLOGY, 7TH EDITION BY KARCH COMPLETE UPDATED QUESTIONS AND CORRECT ANSWERS 100% PASS GUARANTEED

Puntuación

Vendido

Páginas

445

Grado

A+

Subido en

12-09-2025

Escrito en

2025/2026

1.A nurse working in radiology administers iodine to a patient who is having a computerized axial tomography (CAT) scan. A nurse working on an oncology unit administers chemotherapy to patients who have cancer. At the Public Health Department, a nurse administers a measles-mumps-rubella (MMR) vaccine to a 14- month-old child as a routine immunization. Which branch of pharmacology best describes the actions of all three nurses? A) Pharmacoeconomics B) Pharmacotherapeutics C) Pharmacodynamics D) Pharmacokinetics Ans: B Response: Pharmacology is the study of the biologic effects of chemicals. Nurses are involved with clinical pharmacology or pharmacotherapeutics, which is a branch of pharmacology that deals with the uses of drugs to treat, prevent, and diagnose disease. The nurse working in radiology is administering a drug to help diagnose a disease. The nurse working on an oncology unit is administering a drug to help treat a disease. Pharmacoeconomics includes any costs involved in drug therapy. Pharmacodynamics involves how a drug affects the body, and pharmacokinetics is how the body acts on the drug. Cognitive Level: Comprehension Difficulty: Easy Integrated Process: Nursing process 2.A physician has ordered intramuscular injections of morphine, a narcotic, every 4 hours as needed for pain for a motor vehicle accident victim. The nurse is aware that there is a high abuse potential for this drug; therefore, morphine is categorized as a: A) Schedule I drug B) Schedule II drug C) Schedule III drug D) Schedule IV drug Ans: B Response: Narcotics such as morphine are considered schedule II drugs because of the high abuse potential with severe dependence liability. Schedule I drugs have high abuse potential and no accepted medical use. Schedule III drugs have a lesser abuse potential than schedule II drugs and an accepted medical use. Schedule IV drugs have low abuse potential and limited dependence liability. Cognitive Level: Comprehension Difficulty: Easy Integrated Process: Communication and documentation 3.A nurse working for a drug company is involved in phase III drug evaluation studies. Which of the following might the nurse be responsible for during this stage of drug development? Chapter 1: Introduction to Drugs A) Working with animals who are given experimental drugs B) Monitoring drug effects in patients who are selected to participate in a study, who have the disease that the drug is meant to treat C) Collecting records of symptoms that participants experience while taking a drug and determining whether they are caused by the disease or the drug D) Informing healthy, young volunteer participants of possible risks that could occur from taking an experimental drug Ans: C Response: Phase III studies involve use of a drug in a vast clinical market where patients are asked to record any symptoms they experience while taking the drugs. Nurses may be responsible for helping collect and analyze the information to be shared with the Food and Drug Administration (FDA). Use of animals in drug testing is done in the preclinical trials. A select group of patients who are involved in phase II studies participate in studies where the participants have the disease the drug is intended to treat. These patients are monitored closely for drug effects. Phase I studies involve healthy human volunteers who are usually paid for their participation. Nurses may observe for adverse effects and toxicity. Cognitive Level: Comprehension Difficulty: Moderate Integrated Process: Nursing Process 4.Which of the following concepts is considered when generic drugs are substituted for brand-name drugs? A) Bioavailability B) Critical concentration C) Distribution D) Half-life Ans: A Response: Bioavailability is the portion of a dose of a drug that reaches the systemic circulation and is available to act on body cells. Binders used in a generic drug may not be the same as those used in the brand-name drug. Therefore, the way the body breaks down and uses the drug may differ, which may eliminate a substitution. Critical concentration is the amount of a drug that is needed to cause a therapeutic effect. Distribution is the phase of pharmacokinetics that involves the movement of a drug to the body's tissues. A drug's half-life is the time it takes for the amount of drug to decrease to one-half of the peak level. Cognitive Level: Analysis Difficulty: Difficult Integrated Process: Teaching/learning 5.A nurse is teaching her patient about the use of over-the-counter (OTC) drugs. Which of the following statements best informs the patient about their safe use? A) ―OTC drugs are products that are available without prescription for self- treatment of minor complaints.‖ B) ―OTC drugs are considered medications and should be reported on a drug history.‖ Chapter 1: Introduction to Drugs C) ―OTC drugs were approved as prescription drugs but later were found to be safe without the need for a prescription.‖ D) ―OTC drugs need to be taken with caution. They can mask the signs and symptoms of an underlying disease and interfere with prescription drug therapy.‖ Ans: D Response: OTC drugs are considered medications and should be reported. OTC drugs are available without a prescription, although some were first approved as prescription drugs. The most important teaching should relate to their safe use and that OTC drugs can mask symptoms of disease and interfere with prescribed drugs. Cognitive Level: Knowledge Difficulty: Easy Integrated Process: Nursing Process 6.Which of the following legislative acts allowed the Food and Drug Administration (FDA) to tighten control over the quality of drugs and required that safety and efficacy standards be established? A) Pure Food and Drug Act of 1906 B) Federal Food, Drug, and Cosmetic Act of 1938 C) Durham Humphrey Amendment of 1951 D) Kefauver-Harris Act of 1962 Ans: D Response: The Kefauver-Harris Act was the result of the use of the 1960s drug thalidomide (Thalomid). The public concern led to the legislation that gave the FDA regulatory control over testing and evaluating of drugs and allowed it to set standards for efficacy and safety. The Pure Food and Drug Act required labeling to eliminate false claims. The Federal Food, Drug, and Cosmetic Act gave the FDA the power to enforce standards for testing drug toxicity and monitoring labeling. The Durham- Humphrey Amendment enforced prescriptions for distribution. Cognitive Level: Application Difficulty: Moderate Integrated Process: Teaching/learning

Mostrar más Leer menos

Institución

Nursing

Grado

Nursing

Ups! No podemos cargar tu documento ahora. Inténtalo de nuevo o contacta con soporte.

Informar violación de derechos de autor

Libro relacionado

Amy Karch Nursing Pharmacology

Edición:2021
ISBN:9798485356286
Edición:Desconocido

Escuela, estudio y materia

Institución: Nursing
Grado: Nursing

Información del documento

Subido en: 12 de septiembre de 2025
Número de páginas: 445
Escrito en: 2025/2026
Tipo: Examen
Contiene: Preguntas y respuestas

Temas

9798485356286
test bank for focus on nursing pharmacology 7thedi

Vista previa del contenido

01206789
45 45 45 2 88 2857 7 0108697
45 45 45 45 45 45

, 0123456789 51571825082012
5145

!%&'(!)*+,-)().!+/0"
"
"#$ "#$ "#$ "#$

123456578;878<=
>??<5@A6524B5CC5@D<6E=
9:

F2G8HA68
9: 9:

I4683HA68G:H2@8JJ= KDHJ543?H2@8JJ
9 :

LM>4DHJ8N2HO54354HAG52<23EAGP545J68HJ52G54862A?A65846NQ25JQA7543A
9: 9 : 9:

@2P?D68H5R8GAS5A<62P23HA?QET1>UVJ@A4M>4DHJ8N2HO54324A424@2<23ED456
9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9:

AGP545J68HJ@Q8P26Q8HA?E62?A65846JNQ2QA78@A4@8HM>66Q8:DW<5@X8A<6Q
9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9:

B8?AH6P846YA4DHJ8AGP545J68HJAP8AJ<8JZPDP?JZHDW8<<ATFF[V7A@@54862A
9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9:

L\ZP246QZ2<G@Q5<GAJAH2D65485PPD45RA6524M]Q5@QWHA4@Q2C?QAHPA@2<23E
9: 9: 9: 9: 9: 9: 9: 9: 9: 9:

W8J6G8J@H5W8J6Q8A@6524J2CA<<6QH884DHJ8J^
9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9:

>V :QAHPA@28@242P5@J
9: 9: 9: 9: 9: 9: 9: 9:

_V :QAHPA@26Q8HA?8D65@J
1V :QAHPA@2GE4AP5@J
BV :QAHPA@2O54865@J
>4J= _
` 0
)(0&"
:QAHPA@2<23E5J6Q8J6DGE2C6Q8W52<235@8CC8@6J2C@Q8P5@A<JMKDHJ8JAH85472<78G
N56Q@<545@A<?QAHPA@2<23E2H?QAHPA@26Q8HA?8D65@JYNQ5@Q5JAWHA4@Q2C
9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9:

?QAHPA@2<23E6QA6G8A<JN56Q6Q8DJ8J2CGHD3J626H8A6Y?H87846YA4GG5A342J8
9: 9: 9: 9: 9: 9: 9: 9: 9: 9:

G5J8AJ8MUQ84DHJ8N2HO54354HAG52<23E5JAGP545J68H543AGHD362Q8<?G5A342J8A
9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9:

G5J8AJ8MUQ84DHJ8N2HO54324A424@2<23ED4565JAGP545J68H543AGHD362Q8<?6H8A6
9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9:

AG5J8AJ8M:QAHPA@28@242P5@J54@<DG8JA4E@2J6J5472<78G54GHD36Q8HA?EM
9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9:

:QAHPA@2GE4AP5@J5472<78JQ2NAGHD3ACC8@6J6Q8W2GEYA4G?QAHPA@2O54865@J
9: 9: 9: 9: 9: 9: 9: 9: 9: 9:

5JQ2N6Q8W2GEA@6J246Q8GHD3M
9: 9: 9: 9: 9: 9: 9: 9: 9:

9: 9: 9: 9: 9: 9: 9: 9:

123456578;878<=
12P?H8Q84J524B5CC5@D<6E=aAJE
9:

I4683HA68G:H2@8JJ= KDHJ543?H2@8JJ
9: 9: 9:

bM>?QEJ5@5A4QAJ2HG8H8G546HAPDJ@D<AH54c8@6524J2CP2H?Q548YA4AH@265@Y878HE\
9: 9 : 9:

Q2DHJAJ488G8GC2H?A54C2HAP262H78Q5@<8A@@5G84675@65PMUQ84DHJ85JANAH8
9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9:

6QA66Q8H85JAQ53QAWDJ8?268465A<C2H6Q5JGHD3d6Q8H8C2H8YP2H?Q5485J@A6832H5R8GAJ
9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9:

A=
9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9:

>V e@Q8GD<8IGHD3
9:

_V e@Q8GD<8IIGHD3
9: 9:

1V e@Q8GD<8IIIGHD3
9: 9:

BV e@Q8GD<8IfGHD3
9: 9:

>4J= _
9: 9:

` 0
)(0&"
KAH@265@JJD@QAJP2H?Q548AH8@24J5G8H8GJ@Q8GD<8IIGHD3JW8@ADJ82C6Q8Q53Q
AWDJ8?268465A<N56QJ878H8G8?84G84@8<5AW5<56EMe@Q8GD<8IGHD3JQA78Q53QAWDJ8
9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9:

?268465A<A4G42A@@8?68GP8G5@A<DJ8Me@Q8GD<8IIIGHD3JQA78A<8JJ8HAWDJ8
9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9:

?268465A<6QA4J@Q8GD<8IIGHD3JA4GA4A@@8?68GP8G5@A<DJ8Me@Q8GD<8IfGHD3J
9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9:

QA78<2NAWDJ8?268465A<A4G<5P568GG8?84G84@8<5AW5<56EM
9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9:

9: 9: 9: 9: 9: 9: 9: 9:

123456578;878<=
12P?H8Q84J524B5CC5@D<6E=aAJE
9:

I4683HA68G:H2@8JJ= 12PPD45@A6524A4GG2@DP846A6524
9: 9: 9:

gM>4DHJ8N2HO543C2HAGHD3@2P?A4E5J5472<78G54?QAJ8IIIGHD387A<DA6524
9: 9 : 9: 9:

J6DG58JM]Q5@Q2C6Q8C2<<2N543P53Q66Q84DHJ8W8H8J?24J5W<8C2HGDH5436Q5JJ6A38
9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9:

2CGHD3G878<2?P846^
9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9: 9:

9: 9: 9:

, 0123456 464 4
6
89 89 89

89

#
$%&
'&()#%&
*
+**,-*

'*$&(.
/)
0 1
$

.
/ *22*3$)
-&$
*$)#%&
*)*(*3$*.$-&
$
3
-&$*
&
!" !" !" !" !" !" !"

)$/.45#%%&+*$%*.
)*&)*$%&$$%*.
/
)'*&$$$
*&$
!" !" !" !" !" !" !" !" !" !" !"

6 6((*3$

*3
.)2)4'-$')$%&$-&
$
3
-&$)*,-*

*3*#%
(*$&

!" !" !" !" !" !" !" !" !" !" !" !"

&.
/ &..*$*
'

#%*$%*
$%*4&
*3&/)*.74$%*.
)*&)*
$%*.
/
!" !" !" !" !" !" !" !"

8 92
'
%*&($%454/ +(/$**
-&
$
3
-&$)2-))
7(*

)
)$%&$
!" !" !" !" !" !" !" !" !" !" !" !" !" !"

3/(.33/
2
'$&

&*,-*

'*$&(.
/
!" !" !" !" !" !" !" !"

): 6
!" !" !" !" !" !" !"

;535
"%&)*999)$/.
*)
+(+*/)*2&.
/
&+&)$3(

3&('&

*$#%*
*-&$
*$)&
*
&)
*.$
*3
.&4)4'-$')$%*4*,-*

*3*#%
(*$&

$%*.
/)<=/
)*)'&4
!" !" !" !" !" !" !" !" !" !" !" !" !" !" !"

7*
*)-)
7(*2
%*(-
3((*3$&.&&(4>*$%*
2
'&$
$7*)%&
*.#
$%$%*
!" !" !" !" !" !" !" !" !" !" !" !" !"

?.&.8
/ .'

)$
&$
@?8<A)*2&
'&()
.
/ $*)$

).*
$%*
!" !" !" !" !" !" !" !" !" !" !" !" !" !"

-
*3(

3&($

&()<)*(*3$
/-2-&$
*$)#%&
*
+(+*.
-%&)*99)$/.
*)
!" !" !" !" !" !" !" !" !" !" !" !" !" !" !"

-&
$
3
-&$*
)$/.
*)#%*
*$%*-&
$
3
-&$)%&+*$%*.
)*&)*$%*.
/
)
$*.*.$
!" !" !" !" !" !" !" !" !" !" !" !" !" !"

$
*&$<B%*)*-&$
*$)&
*'
$
*.3()*(42
.
/ *22*3$)<"%&)*9)$/.
*)
+(+*
!" !" !" !" !" !" !" !" !" !" !" !" !" !"

%*&($%4%/'&+(/$**
)#%&
*/)/&((4-&
.2
$%*

-&
$
3
-&$
<=/
)*)'&4
!" !" !" !" !" !" !" !" !" !" !" !" !"

7)*
+*2
&.+*
)**22*3$)&.$,
3
$4<
!" !" !" !" !" !" !" !" !" !" !" !"

!" !" !" !" !" !"

6
$
+*C*+*(:
6'-
*%*)
8
22
3/($4:
!"

1.*
&$*
!" !"

9$*
&$*."
3*)): =/
)
"
3*))
! "

D<%
3%2$%*2((#
33*-$)
)3)
.*
*.#%* **

3.
/)&
*)/7)$
$/$*.
!" ! " !"

2
7
&.E&'*.
/)F
!" !" !" !" !" !" !" !" !" !" !"

0
&+&
(&7
(
$4
!" !" !"

0 6

$
3&(33*$
&$

6 8
)$

7/$

!"

8 G&(2E(
2*
):
;535
0
&+&
(&7
(
$4
)$%*-
$
2&.)*2&.
/ $%&$
*&3%*)$%*)4)$*'
33

3/(&$

&.
)&+&
(&7(*$&3$7.43*(()<0
.*
)/)*.
& **

3.
/ '&4$7*$%*
!" !" !" !" !" !" !" !" !" !" !" !" !" !"

)&'*&)$%)*/)*.
$%*7
&.E&'*.
/<B%*
*2
*5$%*#&4$%*7.47
*&
)
!" !" !" !" !" !" !" !" !" !" !" !" !" !" !" !" !" !"

.#&./)*)$%*.
/ '&4.
22*
5#%
3%'&4*(
'
&$*&)/7)$
$/$
<6

$
3&(
!" !" !" !" !" !" !" !" !" !" !" !" !" !"

33*$
&$

)$%*&'/$2&.
/ $%&$
)**.*.$3&/)*&$%*
&-*/$
3*22*3$<
!" !" !" !" !" !" !" !" !" !" !" !" !"

8
)$

7/$

)$%*-%&)*2-%&
'&3

*$
3)$%&$
+(+*)$%*'+*'*$2&.
/
!" !" !" !" !" !" !" !" !" !" !" !" !" !" !"

$$%*7.4H)$
))/*)<.
/H)%&(2E(
2*
)$%*$
'*
$$&
*)2
$%*&'/$2.
/ $
!" !" !" !" !" !" !" !" !" !" !" !"

.*3
*&)*$*E%&(22$%*-*&
(*+*(<
!" !" !" !" !" !" !" !" !" !" !" !" !" !" !" !" !" !"

!" !" !" !" !" !" !"

6
$
+*C*+*(:
&(4)
)8
22
3/($4: 8
22
3/($
!"

9$*
&$*."
3*)):B*&3%
I(*&

!" !" ! "

J</
)*
)$*&3%
%*
-&$
*$&7/$$%*/)*2+*
E$%*E3/$*
@KB6.
/)<
!" ! "

%
3%2$%*2((#
)$&$*'*$)7*)$
2
')$%*-&$
*$&7/$$%*

)&2*/)*F
!" !" !" !" !" !" !" !" !" !" !" !"

LKB6.
/)&
*-
./3$)$%&$&
*&+&
(&7(*#
$%/$-
*)3

-$
2
)*(2E
!" !" !" !" !" !" !" !" !" !" !" !" !"

$
*&$'*$2'

MNOPQRSTUVWX
!" !" !" !" !" !" !" !" !" !"

0 LKB6.
/)&
*3)
.*
*.'*.
3&$
)&.)%/(.7*
*-
$*.&.
/
!" !" !" !"

YSVUNZ[WX
!" !" !" !" !" !" !" !" !" !" !"

!"

, 0123456 464 4
6
89 89 89

89

!"#$%%&''()%&#'%#*+',+(-!"#.!,/&,%$%%0(!-,(.%
#&0%$+,1(!,,1%-%%0( &23456372879:;<

=
!"#-%%,(.%,&>%-$+,1*&!,+(-?
1%@*&-A&#>,1%#+"-#&-

#@A',(A#(0&-!-%/@+-"+#%&#%&-+-,%0%%$+,1'%#*+',+(-!"

8B43C2D;<

E-#F =

G535

!"#&%*(-#+%%A%+*&,+(-#&-#1(!/.%%'(,%?
!"#&%
&)&+/&./%$+,1(!,&'%#*+',+(-H&/,1(!"1#(A%$%%0+#,&''()%&#'%#*+',+(-

!"#?
1%A(#,+A'(,&-,,%&*1+-"#1(!/ %/&,%,(,1%+#&0%!#%&-,1&,

!"#*&-A&#>#@A',(A#(0+#%&#%&-+-,%0%%$+,1'%#*+.%!"#?

("-+,+)%I%)%/F
J-($/%"%=+00+*!/,@FK&#@

L-,%"&,%
(*%##F M!#+-"
(*%##

N?O1+*1(0,1%0(//($+-"/%"+#/&,+)%&*,#&//($%,1%P((&-= !"

EA+-+#,&,+(-QP=E,(,+"1,%-*(-,(/()%,1%R!&/+,@(0!"#&- %R!+%,1&,

#&0%,@&-%00+*&*@#,&-&#.%%#,&./+#1%S

E
!%P((&-=!"E*,(0TUVN

W P%%&/P((H=!"H&-(#A%,+*E*,(0TUXY

=!1&AZ!A'1%@EA%-A%-,(0TU[T

= J%0&!)%\Z& +#E*,(0TUN]

E-#F =

G535

1%J%0&!)%\Z& +#E*,$&#,1%%#!/,(0,1%!#%(0,1%TUNV#!",1&/+(A+%
Q^_`abcde?
1%'!./+**(-*%-/%,(,1%/%"+#/&,+(-,1&,"&)%,1%P=E %"!/&,(@

*(-,(/()%,%#,+-"&-%)&/!&,+-"(0!"#&-&//($%+,,(#%,#,&-&#0(

%00+*&*@&-#&0%,@?
1%
!%P((&-=!"E*,%R!+%/&.%/+-",(%/+A+-&,%

0&/#%*/&+A#?
1%P%%&/P((H=!"H&-(#A%,+*E*,"&)%,1%P=E,1%'($%,(

%-0(*%#,&-&#0( ,%#,+-"!",(f+*+,@&-A(-+,(+-"/&.%/+-"?
1%=!1&A\

Z!A'1%@EA%-A%-,%-0(*%'%#*+',+(-#0( +#,+.!,+(-?

("-+,+)%I%)%/F
E''/+*&,+(-=+00+*!/,@F

g(%&,%

L-,%"&,%
(*%##F
%&*1+-"h/%&-+-"

i?E-!#%+#+-#,!*,+-"&'%"-&-,'&,+%-,*(-*%-+-",1%'(,%-,+&/+#>,(1%

0%,!#0(A&'%"-&-*@*&,%"(@W!"?
1%-!#%$(!/+-0(A,1%'&,+%-,,1&,F

E E%R!&,%#,!+%#+-'%"-&-,$(A%-1&)%%A(-#,&,%,1%%+#-( +#>,(,1%

j48k5;<

W E-+A&/#,!+%#1&)%-(,%A(-#,&,%&+#>,(,1%0%,!#.!,,1%%1&)%.%%-

-(&%R!&,%#,!+%#+-'%"-&-,l9m4:;<

E-+A&/#,!+%#1&)%#1($-&-&)%#%%00%*,(-,1%0%,!#.!,,1%%&%-(

&%R!&,%#,!+%#+-'%"-&-,l9m4:;<

=
1%%+#%)+%-*%(01!A&-0%,&/+#>.!,,1%'(,%-,+&/.%-%0+,#0(A!#%(0,1%

!"A&@.%&**%',&./%%#'+,%'(,%-,+&/375n5;<

E-#F W

G535
&,%"(@W+-+*&,%#,1&,&-+A&/#,!+%#1&)%-(,%A(-#,&,%&+#>,(,1%0%,!#.!,

$21.49

Accede al documento completo:

100% de satisfacción garantizada

Inmediatamente disponible después del pago

Tanto en línea como en PDF

No estas atado a nada

Conoce al vendedor

Studix

3.4

(8)

Conoce al vendedor

Studix Chamberlain College Of Nursing

Ver perfil

Seguir

Vendido

Miembro desde

1 año

Número de seguidores

Documentos

1019

Última venta

1 semana hace

STUDIXHUB

STUDIXHUB Welcome to your one-stop destination for high-quality academic resources! Here you’ll find test banks, solution manuals, ATI study guides, iHuman case studies, nursing exam prep materials, and verified textbook answers — all carefully selected to help you study smarter and score higher. Whether you’re preparing for nursing exams, business courses, medical case studies, or general college tests, this store offers reliable, up-to-date materials used by top students worldwide. Popular categories include: ✅ Test Banks & Solution Manuals ✅ ATI & HESI Study Guides ✅ iHuman Case Studies & Answers ✅ NCLEX & Nursing Exam Prep ✅ Business, Accounting & Economics Test Banks ✅ Psychology, Biology & Anatomy Materials Boost your academic performance with expertly curated resources that match real exams and class content.

Lee mas Leer menos

3.4

8 reseñas

Recientemente visto por ti

Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

100% de satisfacción garantizada: ¿Cómo funciona?

Nuestra garantía de satisfacción le asegura que siempre encontrará un documento de estudio a tu medida. Tu rellenas un formulario y nuestro equipo de atención al cliente se encarga del resto.

Who am I buying this summary from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller Studix. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy this summary for $21.49. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews) 45,681 summaries were sold in the last 30 days Founded in 2010, the go-to place to buy summaries for 16 years now